

Colgate-Palmolive vs Ambev
Global oral care leader with steady household sales vs Leading Latin American brewer and beverage producer. Which is the better buy for your portfolio in October 2026? Plain-English answer below.
Colgate-Palmolive is an American consumer staples institution with dominant toothpaste and personal care brands distributed across more than 200 countries and a pricing power track record built over more than a century, while Ambev is the undisputed dominant beer and soft drinks company across Latin America, with volume scale across Brazil and neighboring markets that rivals simply can't match cost-effectively. Colgate-Palmolive vs Ambev puts two powerful consumer goods franchises in direct comparison, both earning high returns on capital and both navigating meaningful emerging market currency exposure in their international businesses. Readers find a detailed examination of organic volume versus pricing growth, dividend payout sustainability, cost structure flexibility, and which franchise delivers more reliable earnings through a global consumption slowdown.
Colgate-Palmolive is an American consumer staples institution with dominant toothpaste and personal care brands distributed across more than 200 countries and a pricing power track record built over m...
Why It’s Moving

Colgate-Palmolive Faces Valuation Scrutiny Ahead of Q3 Earnings Despite Recent Rally
- Shares have risen more than 13% over the last three weeks and 21.87% year-to-date, reflecting a flight to safety amid broader market turbulence.
- The company is expected to deliver earnings growth supported by emerging-market strength, premium innovation, and cost-saving initiatives, with a likely beat on consensus estimates.
- Valuation concerns persist as the adjusted P/E ratio sits at 26x compared to a 10-year average of 24x, reducing the margin of safety for new investors.

Ambev Shares Slide as Brazil’s Shock Election Result Rattles Market
- Shares dropped following Lula da Silva's unexpected win in Sunday's runoff election, which contradicted market expectations favoring the challenger.
- The decline reflects a reversal of the pre-election rally, where investors had piled into Brazil stocks after the October 4 first-round results showed Flávio Bolsonaro ahead.
- Market sentiment shifted sharply negative for Brazilian companies, including Ambev, amid concerns over the country's economic path under the new administration.

Colgate-Palmolive Faces Valuation Scrutiny Ahead of Q3 Earnings Despite Recent Rally
- Shares have risen more than 13% over the last three weeks and 21.87% year-to-date, reflecting a flight to safety amid broader market turbulence.
- The company is expected to deliver earnings growth supported by emerging-market strength, premium innovation, and cost-saving initiatives, with a likely beat on consensus estimates.
- Valuation concerns persist as the adjusted P/E ratio sits at 26x compared to a 10-year average of 24x, reducing the margin of safety for new investors.

Ambev Shares Slide as Brazil’s Shock Election Result Rattles Market
- Shares dropped following Lula da Silva's unexpected win in Sunday's runoff election, which contradicted market expectations favoring the challenger.
- The decline reflects a reversal of the pre-election rally, where investors had piled into Brazil stocks after the October 4 first-round results showed Flávio Bolsonaro ahead.
- Market sentiment shifted sharply negative for Brazilian companies, including Ambev, amid concerns over the country's economic path under the new administration.
Investment Analysis
Pros
- Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
- The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
- Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.
Considerations
- Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
- The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
- Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.

Ambev
ABEV
Pros
- Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
- The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
- Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.
Considerations
- Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
- The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
- Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.
Colgate-Palmolive (CL) Next Earnings Date
Clean Harbors is scheduled to release its next earnings report on October 30, 2026, before the market opens. This upcoming disclosure will cover the company's financial performance for the third quarter of fiscal year 2026. The confirmed date aligns with the firm's historical reporting pattern, which typically occurs approximately three months after the previous quarterly release.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (NYSE: ABEV) is scheduled to release its next earnings report on October 29, 2026. The report will cover the third quarter of fiscal 2026. This date is consistent with the company’s typical late-October reporting schedule.
Colgate-Palmolive (CL) Next Earnings Date
Clean Harbors is scheduled to release its next earnings report on October 30, 2026, before the market opens. This upcoming disclosure will cover the company's financial performance for the third quarter of fiscal year 2026. The confirmed date aligns with the firm's historical reporting pattern, which typically occurs approximately three months after the previous quarterly release.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (NYSE: ABEV) is scheduled to release its next earnings report on October 29, 2026. The report will cover the third quarter of fiscal 2026. This date is consistent with the company’s typical late-October reporting schedule.
Buy CL or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


